Today’s post (#53) may sound slightly technical but I hope to communicate two key complementary modes that our bodies toggle ...

In the latest trading session, Meritor (MTOR) closed at $20.83, marking a -0.19% move from the previous day.

Can this ‘anti-aging’ drug live up to the hype? Here’s what we know. Groundbreaking studies in mice have sparked a frenzy among longevity enthusiasts—but human trials are still in their ...

As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

Researchers describe molecular signalling regulated by mTOR among memory and exhausted cytotoxic CD8+ T lymphocytes.

New research reveals that metformin’s power may start in the brain, reshaping our understanding of blood sugar control and ...

Conclusion FDG-PET is not predictive of proliferative response to mTOR inhibitor therapy in both clinical and preclinical studies. Our findings suggest that mTOR inhibitors suppress the formation of ...

Meritor (MTOR) is a stock many investors are watching right now. MTOR is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock has a Forward P/E ratio of 5.19.